MindMaze Consolidates First-ever FDA Approval for Inpatient and Outpatient Neurorehabilitation Therapy (press release):
“MindMaze, a leader in braintech, has today announced that it has obtained FDA clearance to launch its portable neurorehabilitation product, MindMotion™ GO, in the United States. Together with MindMotion PRO (which received FDA clearance in 2017), MindMotion GO is the next offering in the company’s continuum of care, providing gamified neurorehabilitation therapy. [Read more…] about FDA clears MindMaze GO neurorehabilitation platform, easing access to continued outpatient therapy
Battling Addiction With Brainpower (University of Dayton press release):
“The University of Dayton Research Institute has won a $10,000 Ohio Opioid Technology Challenge award for a program that will teach people with opioid addictions how to reduce their cravings by regaining control of their brains.
“Using neurofeedback, we’ll work with our volunteers to help them learn to regulate activity in the part of their brain associated with cravings and rewire some of those pathways, allowing them to reduce their cravings and experience a more ‘normal’ state even without opioids.” [Read more…] about Ohio Opioid Technology Challenge funds program testing neurofeedback-based brain training to reduce cravings and battle opioid addiction
What a rich and cutting-edge 3‑day conversation last week on the future of brain health and brain enhancement.
We enjoyed dozens of fascinating insights and moments — here’s a sample of our favorites:
1. That masterful 40-minute overview by Dr. Tom Insel on the past, present and future of mental health
2. Discussing with Akili’s Eddie Martucci the FDA implications from the significant research findings released just the day before
4. Discovering the latest in EEG, virtual reality/ augmented reality, and photobiomodulation with experts at UCSF, Emotiv, Stanford, AUGMENTx ad VieLight
Question: Have you ever used–for yourself or for others–technologies or products that you think would fall into the category of brain enhancement? a) If Yes, what did you use and what lessons learned can you share? b) If No, what issues would you like to see addressed before considering doing so?
Note: As a token of appreciation, we will issue 3 complimentary passes for most insightful respondents to participate at the upcoming 2017 SharpBrains Virtual Summit: Brain Health & Enhancement in the Digital Age (December 5–7th). Names will be announced on Monday, November 20th, so please don’t wait to share your insights 🙂
“In 2003, neurologist Helen Mayberg of Emory University in Atlanta began to test a bold, experimental treatment for people with severe depression, which involved implanting metal electrodes deep in the brain in a region called area 25. The initial data were promising; eventually, they convinced a device company, St. Jude Medical in Saint Paul, to sponsor a 200-person clinical trial dubbed BROADEN.
This month, however, [Read more…] about Ethical issues raised around deep brain stimulation (DBS) research